5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2 RESP301 - COPD, Bronchiectasis | Phase 2 | Terminated | Thirty Respiratory Limited | 88 | 2021-03-01 | 2025-01-31 |
| Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis QBW251, Placebo - Bronchiectasis | Phase 2 | Terminated | Novartis Pharmaceuticals | 42 | 2021-02-02 | 2025-09-26 |
| The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases PC945, Placebo - Asthma, Respiratory Candidiasis | Phase 2 | Terminated | Pulmocide Ltd | 13 | 2018-11-15 | 2020-06-12 |
| Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis. POL7080 - Bronchiectasis, Lower Respiratory Infection | Phase 2 | Terminated | Polyphor Ltd. | 20 | 2013-12-01 | 2017-02-01 |
| Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis azithromycin and fluticasone, fluticasone and azithromycin - Bronchiectasis, Pulmonary Disease | Phase 2 | Terminated | University of Milan | 210 | 2006-09-01 | 2009-03-13 |
Pulmonary Disease, Chronic Obstructive (2) · Asthma (1) · Bronchitis, Chronic (1) · Lung Diseases (1) · Pseudomonas Infections (1)
Bronchial Diseases (5) · Respiratory Tract Diseases (5) · Chronic Disease (3) · Disease Attributes (3) · Lung Diseases, Obstructive (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Infections (2) · Lung Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchitis (1) · Gram-Negative Bacterial Infections (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1)
Azithromycin (1) · Fluticasone (1) · icenticaftor (1) · murepavadin (1)
Novartis Pharmaceuticals (1) · Polyphor Ltd. (1) · Pulmocide Ltd (1) · Thirty Respiratory Limited (1) · University of Milan (1)
United Kingdom (4) · Spain (2) · China (1) · Germany (1) · Italy (1)
Adam Hill, MD PhD (1) · Eva Polverino, MD (1) · Francesco Blasi, MD (1)
2018 (1)